Seoul, South Korea

Jae Seog Kang

This inventor holds 1 USPTO granted patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Seog Kang. Retrieved from https://idiyas.com/inventor/jae-seog-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae Seog Kang: Innovator in Pyrimidinone Derivatives

Introduction

Jae Seog Kang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his work on pyrimidinone derivatives. His innovative approach has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Jae Seog Kang holds a patent for pyrimidinone derivatives. This patent represents his commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Kang is currently employed at Boryung Pharmaceutical Co., Ltd., where he continues to push the boundaries of innovation in the pharmaceutical industry. His work at Boryung has positioned him as a key player in the development of new medicinal compounds.

Collaborations

Throughout his career, Jae Seog Kang has collaborated with talented individuals such as Woo Hyun Paik and Ji Han Kim. These partnerships have fostered a creative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Jae Seog Kang is a distinguished inventor whose work on pyrimidinone derivatives has made a significant impact in the pharmaceutical field. His dedication to innovation and collaboration continues to drive advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…